TrialLancet (London, England)2021

Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.

Peter Richmond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.